News & Articles

Join us Monday, November 16, to explore the advantages and applications of direct molecular testing

The StarBright Blue 700, StarBright Violet 440 and StarBright Violet 610 dyes aim to offer maximal brightness for improved resolution

To expand Minimally Invasive Surgery field by reinforcing its orthopedics business

Study by University of Manchester reassures patients that it is safe to take blood pressure medication during the pandemic

Which new products made the most difference to your lab work this year?

New kit aims to provide highly sensitive and efficient approach for studying mitophagy impairment in conditions such as Parkinson’s and Alzheimer’s

The study leverages the Tapestri Platform to illustrate the single-cell atlas of acute myeloid leukemia (AML) with multi-omics, describing the clonality underlying therapeutic resistance

The collaboration will focus on the investigation of clinically relevant molecular targets for use in the development of advanced diagnostic testing for epilepsy

Veklury is first FDA-approved treatment for COVID-19 in the US, and aims to shorten time to recovery by five days

The hypercube algorithm aims to enable regular, cost-effective screening in multiple contexts

Join us Thursday, November 5, to learn how to introduce base editing technology into your cell therapy pipeline

The test uses a convolutional neural network to classify microscopy images of single intact particles of different viruses

Availability of the new IgM blood test on the ARCHITECT and Alinity platforms is part of Abbott's effort to offer tests across the disease progression of COVID-19

Easy-to-use test, which doesn't require specialized laboratory personnel or instruments, promises flexibility to test in locations that benefit from immediate results

The CTS Rotea system aims to help researchers overcome manufacturing hurdles and bring the vast potential of cell therapies to more patients

Find out how experts at the Ellison Institute are harnessing new cell monitoring technology to build cancer cell biobanks and enhance cell line quality control and authentication

Partnership combines Twist’s leadership in DNA synthesis and synthetic biology with Neogene’s expertise in personalized engineered T cell therapies

Antibodies available are specific for S1, S2 and receptor-binding domain regions of SARS-CoV-2 Spike protein

The CleanPlex ACE2 & TMPRSS2 Panel assesses differences in patients’ genetic susceptibility to COVID-19 infection and to developing severe disease

EpiMOGRIFY supports the development of scalable off-the-shelf cell therapies for diseases with a high unmet clinical need

Combination test for COVID-19, flu and other common respiratory illnesses helps health care professionals prepare for flu season

The Phase II clinical trial, which will use cutting-edge CRISPR genetic engineering, has already begun enrolling patients

The addition of COVID-19 antibody tests to the portfolio aims to further support the pandemic response on multiple fronts

Access SARS-CoV-2 IgG assay shows excellent agreement with the Genscript Surrogate Virus Neutralization Test

Fluidigm COVID-19 campus safeguard program improves availability of non-invasive, saliva-based SARS-CoV-2 tests for higher education institutions